BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study
Conditions
Non Small Cell Lung Cancer
What is the purpose of this trial?
PURPOSE OF STUDY Different people have different biomarkers (chemical "markers" in the blood that may be related to your reaction to study drugs). If researchers know about your biomarkers before you receive treatment, they may be able to prescribe a treatment that is better suited to your body's specific needs. The goal of this clinical research study is to learn if a drug or drug combinations based on your biomarkers can help to control NSCLC. The safety of these drug combinations will also be studied.Participation Guidelines
- Age:
- 18 and older
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- MD Anderson Cancer Center
- Dates:
- Last Updated:
- Study HIC#:
- 1108008990
Clinicaltrials.gov ID: Yale0186992
Investigators
Roy Herbst, MD, PhD
Principal Investigator
Anne Chiang, MD, PhD
Sub-Investigator
Daniel Morgensztern, MD
Sub-Investigator
Marianne Davies,
Sub-Investigator
Rebecca Sipples,
Sub-Investigator
Sarah Goldberg, MD, MPH
Sub-Investigator
Scott Gettinger, MD
Sub-Investigator
